Cotización Q32 Bio - QTTB

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

3.20

Postura de Compra

3.20

Postura de Venta

3.21

Volume Operado de la Acción

93,443

3.16 Rango del Día 3.29

3.02 Rango de 52 semanas 53.79

Precio Anterior

3.23

Precio de Apertura

3.29

Hora

3.2004

Última hora de negociación

10:04:07

Volumen promedio (3 m)

293,762

Volumen financiero

US$ 300,145

Precio Promedio Ponderado

3.2121

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...

Form 4 - Statement of changes in beneficial ownership of securities

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 PR Newswire WALTHAM, Mass., Oct. 14...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.24	-6.97674418605	3.44	3.77	3.02	661964	3.35913924	CS
4	-23.65	-88.0819366853	26.85	28.66	3.02	709611	6.4197786	CS
12	-41.69	-92.8714635776	44.89	53.17	3.02	293762	14.29751724	CS
26	-12.35	-79.421221865	15.55	53.79	3.02	198495	21.01936821	CS
52	-13.04	-80.2955665025	16.24	53.79	3.02	149479	21.35556503	CS
156	-13.04	-80.2955665025	16.24	53.79	3.02	149479	21.35556503	CS
260	-13.04	-80.2955665025	16.24	53.79	3.02	149479	21.35556503	CS

QTTB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Q32 Bio?

El precio actual de las acciones de Q32 Bio es US$ 3.20

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Q32 Bio?

Q32 Bio ha negociado en un rango de US$ 3.02 a US$ 53.79 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
BAOSBaosheng Media Group Holdings Ltd	US$ 8.28 (378.61%)	46.31M
HOURHour Loop Inc	US$ 4.4701 (212.59%)	57.18M
CREVCarbon Revolution Public Ltd	US$ 9.95 (155.78%)	22.6M
AVGRAvinger Inc	US$ 1.47 (128.83%)	78.18M
JTAIJet AI Inc	US$ 6.49 (89.77%)	31.21M
SLGLSol Gel Technologies Ltd	US$ 0.96 (-41.82%)	2.27M
CHEKCheck Cap Ltd	US$ 1.3399 (-40.45%)	2.38M
RENBRenovaro Inc	US$ 0.68429 (-38.90%)	2.1M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF	US$ 15.39 (-30.74%)	99.05k
DRCTDirect Digital Holdings Inc	US$ 3.85 (-30.00%)	19.35M
SVMHSRIVARU Holding Ltd	US$ 0.0334 (19.29%)	251.45M
LITMSnow Lake Resources Ltd	US$ 0.5734 (49.83%)	122.41M
AVGRAvinger Inc	US$ 1.47 (128.83%)	78.18M
LAESSEALSQ Corporation	US$ 5.5699 (13.67%)	70.95M
XTIAXTI Aerospace Inc	US$ 0.0388 (-3.48%)	68.34M